CEL-SCI Corp. (CVM)
6.00
-0.36
(-5.66%)
USD |
NYAM |
Dec 15, 16:00
5.99
-0.01
(-0.17%)
After-Hours: 20:00
CEL-SCI Research and Development Expense (Quarterly): 3.740M for June 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| AIM ImmunoTech, Inc. | 0.525M |
| IGC Pharma, Inc. | 1.588M |
| NovaBay Pharmaceuticals, Inc. | -- |
| Protalix Biotherapeutics, Inc. | 4.467M |
| Palatin Technologies, Inc. | 2.526M |